nAMD: Optimizing Procedural Approaches to Implantable Drug Delivery with Drs. Dante Pieramici, Margaret Chang, and Jordan Graff

0.25CME

15MINS

Already listened on another platform?

Click here to attest to listening to the podcast in order to claim credits.

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Activity Description

In this podcast, Drs. Dante Pieramici and Margaret Chang discuss utilizing implantable drug delivery systems in the management of a patient with neovascular age-related macular degeneration (nAMD).

Target Audience

The intended audience for this activity is retina specialists and ophthalmologists who are involved in the management of patients with nAMD, diabetic retinopathy (DR), or diabetic macular edema (DME).

Learning Objective

Upon successful completion of this activity, participants should be better able to employ procedural techniques to optimize outcomes with surgical and implantable delivery systems for patients with nAMD, DR, or DME.

Activity Chair

Dante J. Pieramici, MD
Director, California Retina Research Foundation
Partner, California Retina Consultants
Santa Barbara, CA

Faculty

Margaret A. Chang, MD, MS
Senior Partner
Retinal Consultants Medical Group
Sacramento, CA

Jordan M. Graff, MD, FACS, FABO
Surgeon & Partner, BDP Eye Center – Retina Division
American Vision Partners (AVP) Medical Executive Team
Phoenix, AZ

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, May 29, 2026, to May 28, 2027.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Margaret A. Chang, MD, MS
Consultant: AbbVie/Regenxbio, Adverum, Annexon, Astellas, Boehringer Ingelheim, EyePoint, Genentech, Ocular Therapeutix, Oculis, Ollin, Outlook
Speaker Contracted by Ineligible Company: Genentech
Independent Research Contractor: 4DMT, Alexion, EyeBio, Kalaris, Kodiak, Novartis, OcuTerra, Outlook, Perceive
Stock Options: Ollin

Jordan M. Graff, MD, FACS, FABO
Advisor: 4DMT, Alimera, Apellis, Astellas, Hi-Health, Ocular Therapeutix, Regeneron, Roche/Genentech
Consultant: Apellis, Hi-Health, Ocular Therapeutix, Roche/Genentech
Speaker Contracted by Ineligible Company: Ocular Therapeutix, Roche/Genentech

Dante J. Pieramici, MD
Consultant: 4DMT, Adverum, Arrowhead, EyePoint, Genentech, Kyowa Kirin, Neurotech, Perceive, Regeneron, Regenxbio, Roche, Unity
Independent Research Contractor: 4DMT, Adverum, Amgen, Apellis, Aviceda, Avirmax, Boehringer Ingelheim, EyePoint, Genentech, Janssen, jCyte, Novartis, Ocular Therapeutix, Oculis, ONL, Ray, Regeneron, Regenxbio, Sanofi, SciNeuro, Stealth, Vantage

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Accessibility

Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners.
Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.